Shanghai MicroPort Endovascular MedTech Co., Ltd. (SHA:688016)

Market Cap	12.37B
Revenue (ttm)	1.18B
Net Income (ttm)	447.44M
Shares Out	121.31M
EPS (ttm)	3.62
PE Ratio	28.14
Forward PE	19.87
Dividend	2.01 (2.01%)
Ex-Dividend Date	Jun 6, 2025

Volume	2,580,490
Average Volume	2,448,654
Open	99.88
Previous Close	100.28
Day's Range	99.88 - 103.82
52-Week Range	78.62 - 135.58
Beta	0.06
RSI	63.49
Earnings Date	Aug 27, 2025

About SHA:688016

Shanghai MicroPort Endovascular MedTech Co., Ltd. engages in the research and development, manufacturing, and sale of aortic and peripheral vascular medical devices in China and internationally. The company’s products include branched aortic stent graft system, thoracic stent graft system, abdominal aortic stent graft and delivery system, bifurcated stent graft system, and other stent graft system in surgical operation, as well as accessories, such as balloon inflation catheter. Shanghai MicroPort Endovascular MedTech Co., Ltd. was incorporated...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2012
• Employees: 826
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688016

Financial Performance

In 2024, SHA:688016's revenue was 1.21 billion, an increase of 1.61% compared to the previous year's 1.19 billion. Earnings were 502.10 million, an increase of 1.96%.